Abstract: In one embodiment, the present application discloses, in part, biologically active compositions comprising a Crila® composition, or an admixture of Crinum latifolium L. dry extract (Crila®) and epigallocatechin gallate (EGCG), wherein the ratio of the Crinum latifolium L. dry extract to EGCG, and their use in the treatment of intramural or subserosal fibroids and various related diseases.
Type:
Application
Filed:
February 28, 2023
Publication date:
May 2, 2024
Applicant:
Altin Biosciences Corporation
Inventors:
Charlotte Sue McKinney, Adam Joshua Payne